Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

0.9057
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
0.79
Today|||52-Week Range
2.75
-59.75%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.91
Today’s open0.89
Day’s range0.88 - 0.92
Volume309,112
Average volume (3 months)697,054
Market cap$94.2M
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+35.48%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book0.85

Competitors

 Today’s
change
Today’s
% change
STDYSteadymed Ltd0.000.00%
GEMPGemphire Therapeutic...0.000.00%
GLMDGalmed Pharmaceutica...0.000.00%
GTXIGTX Inc0.000.00%
Data as of 3:59pm ET, 12/08/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts